31,232 Shares in Envista Holdings Corporation $NVST Acquired by Globeflex Capital L P

Globeflex Capital L P acquired a new stake in Envista Holdings Corporation (NYSE:NVST) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 31,232 shares of the company’s stock, valued at approximately $823,000.

A number of other institutional investors have also recently made changes to their positions in NVST. Quantbot Technologies LP bought a new position in shares of Envista in the second quarter worth approximately $199,000. Evolve Private Wealth LLC bought a new stake in Envista during the 2nd quarter valued at $3,584,000. Landscape Capital Management L.L.C. purchased a new stake in Envista during the 2nd quarter valued at $1,017,000. EP Wealth Advisors LLC purchased a new stake in Envista during the 2nd quarter valued at $642,000. Finally, Ieq Capital LLC bought a new stake in Envista in the 2nd quarter worth $7,606,000.

Envista Stock Performance

Shares of Envista stock opened at $27.34 on Tuesday. Envista Holdings Corporation has a 12 month low of $18.77 and a 12 month high of $30.42. The firm has a market capitalization of $4.39 billion, a P/E ratio of 47.15, a P/E/G ratio of 1.30 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The business has a fifty day simple moving average of $26.95 and a two-hundred day simple moving average of $26.33.

Envista (NYSE:NVST) last released its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities analysts forecast that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Envista news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president owned 27,321 shares in the company, valued at approximately $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have issued reports on NVST. Piper Sandler restated a “neutral” rating and issued a $28.00 price objective (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. Robert W. Baird set a $34.00 target price on shares of Envista in a report on Thursday, August 6th. Weiss Ratings raised Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. boosted their price target on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Zacks Research raised Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, Envista presently has an average rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.